
### [MONDO:0019013](http://purl.obolibrary.org/obo/MONDO_0019013)
**Label:** non-histaminic angioedema

**Subclasses:** [MONDO:0019624](http://purl.obolibrary.org/obo/MONDO_0019624) (acquired angioedema), [MONDO:0015055](http://purl.obolibrary.org/obo/MONDO_0015055) (acquired angioedema type 2), [MONDO:0015056](http://purl.obolibrary.org/obo/MONDO_0015056) (acquired angioedema type 1), [MONDO:0015057](http://purl.obolibrary.org/obo/MONDO_0015057) (Renin-angiotensin-aldosterone system-blocker-induced angioedema), 

**Corr. equiv. classes:** [Orphanet:100056](http://www.orpha.net/ORDO/Orphanet_100056), [Orphanet:100057](http://www.orpha.net/ORDO/Orphanet_100057), [OMIM:300909](http://purl.obolibrary.org/obo/OMIM_300909), [Orphanet:100055](http://www.orpha.net/ORDO/Orphanet_100055), [Orphanet:91385](http://www.orpha.net/ORDO/Orphanet_91385), 

**Class expressions from DL-Learner:**

- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 55.36%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 51.62%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 51.62%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology))) 46.73%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity))) 45.00%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response))) 45.00%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response))) 45.00%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0012210](http://purl.obolibrary.org/obo/HP_0012210) (Abnormal renal morphology))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0010935](http://purl.obolibrary.org/obo/HP_0010935) (Abnormality of the upper urinary tract))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0000077](http://purl.obolibrary.org/obo/HP_0000077) (Abnormality of the kidney))) 43.57%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) 39.61%
- [HP:0100665](http://purl.obolibrary.org/obo/HP_0100665) (Angioedema) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 39.61%


